STO : BIOT.ST
$0.2 (0.14%)
STO
Frederic Vanderhaegen
Medical - Instruments & Supplies
Healthcare
BIOT.ST
622
SE
SEK
0.06
2.33
1.55
0.75
0.45
$2.06B
5.58
2.79
46.98
3.05
$3.55
$284M
13.81%
15.95%
7.31%
5.56%
40.34
6.77
6.77
0/5
0 Analysts
%
9.26
7/9
$729M
$4.71B
$862M
$312M
No key metrics data available.
| Name | Title |
|---|---|
| Magnus Nordstedt | Executive Vice President of IT & Digitalization |
| Olof Nord | Executive Vice President of Business Development |
| Scott Carr | Chief Operating Officer |
| Lisa Egelrud | Executive Vice President of Quality Assurance & Regulatory Affairs |
| Raffaella Bombarda | EVice President of Global Marketing |
| Petra Duprez | Chief Human Resources & Sustainability Officer |
| Marc G. Hummersone | Chief Scientific Officer |
| Anders Wikstrom | Executive Vice President of Operations |
| Andreas Juhlin | President of International - EMEA and APAC |
| Andrew Kellett | Chief Financial Officer |
| Frederic Vanderhaegen | Chief Executive Officer & President |
| Jonas Stahlberg | Chief Auditor |
No votes yet today — be the first to share your view!
About Biotage AB (publ) (STO:BIOT.ST) Stock
Biotage AB (publ), established in 1969 and based in Uppsala, Sweden, specializes in providing advanced separation technologies essential for fields such as organic and analytical chemistry, biomolecule research, and industrial scale-up applications. The company offers a comprehensive range of products, including solutions for organic and peptide synthesis, flash chromatography, evaporation, and work-up procedures, along with specialized systems, accessories, and various cartridges (normal, reversed, and specialty phase). Biotage also supplies solutions for plasmid and protein purification, encompassing antibody and tagged protein purification, automation systems, custom packing services, and diverse PhyTip columns. Additionally, they provide extensive sample preparation solutions tailored ... for clinical, bioanalytical, forensic, toxicology, doping control, environmental, and food and agriculture sectors, complemented by necessary consumables. Their offerings further include metal scavengers, reagents, and essential spare parts. Biotage serves a broad client base, including pharmaceutical and biotechnical companies, contract research and manufacturing organizations, government agencies, academic institutions, and various clinical, forensic, and academic laboratories. With a significant global footprint, the company operates in 70 countries across the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Frequently Asked Questions
What is the current Biotage AB (publ) (BIOT.ST) stock price?
Biotage AB (publ)(STO:BIOT.ST) stock price is $143.2 in the last trading session. During the trading session, BIOT.ST stock reached the peak price of $202.2 while $81.6 was the lowest point it dropped to. The percentage change in BIOT.ST stock occurred in the recent session was 0.14% while the dollar amount for the price change in BIOT.ST stock was $0.2.
BIOT.ST's industry and sector of operation?
The STO listed BIOT.ST is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
Who are the executives of BIOT.ST?
Magnus Nordstedt
| Executive Vice President of IT & Digitalization
Olof Nord
| Executive Vice President of Business Development
Scott Carr
| Chief Operating Officer
Lisa Egelrud
| Executive Vice President of Quality Assurance & Regulatory Affairs
Raffaella Bombarda
| EVice President of Global Marketing
How many employees does BIOT.ST have?
Number of BIOT.ST employees currently stands at 622. BIOT.ST operates from Box 8, Uppsala, None 751 03, SE.
Link for BIOT.ST official website?
Official Website of BIOT.ST is: https://www.biotage.com
How do I contact BIOT.ST?
BIOT.ST could be contacted at phone #46 18 56 59 00 and can also be accessed through its website. BIOT.ST operates from Box 8, Uppsala, None 751 03, SE.
How many shares of BIOT.ST are traded daily?
The average number of BIOT.ST shares traded daily for last 3 months was 515.82K.
What is the market cap of BIOT.ST currently?
The market value of BIOT.ST currently stands at $11.46B with its latest stock price at $143.2